Summary
Rising behavioral health spending in Medicaid, especially on Applied Behavior Analysis, has been an increasingly common topic of discussion this year on earnings calls for the big payers and state budget committee hearings. The typical levers states and plans can pull to manage costs, like lowering rates or increasing utilization management, are especially sensitive in the context of therapy for people with Autism Spectrum Disorder.
Positive Development is offering a different therapy modality, Developmental Relationship-Based Interventions, which was recently endorsed by the American Academy of Child & Adolescent Psychiatry in a policy statement as an alternative to ABA. CEO and Cofounder Mike Suiters and Executive Medical Director Dr. Josh Feder joined us to discuss how the DRBI approach differs from ABA, the challenge of measuring quality and value-based care models in behavioral health, and how states are thinking about managing costs when it comes to therapy for patients with ASD.
Check out the conversation below!
Connect & learn more
What we covered:
00:00 Introductions
01:47 Understanding Autism Care Approaches
05:18 Business Model and Insurance Challenges
08:33 Clinical Efficacy and Outcomes
20:45 Cost of Care and Market Dynamics
29:36 Expansion and Future Plans
39:01 Rural Health and Telehealth Strategies
42:24 Conclusion and Resources